Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering

被引：6

作者：

George, SJ ^{[1
]}

Dhond, AJ ^{[1
]}

Alderson, SM ^{[1
]}

Ezekowitz, MD ^{[1
]}

机构：

[1] Drexel Univ, Coll Med, Dept Med, Philadelphia, PA 19102 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2002年 / 90卷 / 11期

关键词：

D O I：

10.1016/S0002-9149(02)02841-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Although the preponderance of evidence has failed to demonstrate a significant relation between cholesterol and risk of stroke, hepatic hydroxymethylglutaryl coenzyme A reductase inhibitors have been shown to be neuroprotective. This benefit may be independent of cholesterol lowering.

引用

页码：1237 / +

页数：4

共 37 条

[1] Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice
Amin-Hanjani, S
Stagliano, NE
Yamada, M
Huang, PL
Liao, JK
Moskowitz, MA
[J]. STROKE, 2001, 32 (04) : 980 - 985
[2] LOVASTATIN INHIBITS LOW-DENSITY-LIPOPROTEIN OXIDATION AND ALTERS ITS FLUIDITY AND UPTAKE BY MACROPHAGES - INVITRO AND INVIVO STUDIES
AVIRAM, M
DANKNER, G
COGAN, U
HOCHGRAF, E
BROOK, JG
[J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (03): : 229 - 235
[3] Stroke, statins, and cholesterol - A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors
Blauw, GJ
Lagaay, AM
Smelt, AHM
Westendorp, RGJ
[J]. STROKE, 1997, 28 (05) : 946 - 950
[4] Byington RP, 2001, CIRCULATION, V103, P387
[5] Vastatins inhibit tissue factor in cultured human macrophages - A novel mechanism of protection against atherothrombosis
Colli, S
Eligini, S
Lalli, M
Camera, M
Paoletti, R
Tremoli, E
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (02) : 265 - 272
[6] Cooper R, 2000, CIRCULATION, V102, P3137
[7] Inhibition of tissue-factor-mediated thrombin generation by simvastatin
Ferro, D
Basili, S
Alessandri, C
Cara, D
Violi, F
[J]. ATHEROSCLEROSIS, 2000, 149 (01) : 111 - 116
[8] Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia
Ferro, D
Parrotto, S
Basili, S
Alessandri, C
Violi, F
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (02) : 427 - +
[9] AN OVERVIEW OF TRIALS OF CHOLESTEROL-LOWERING AND RISK OF STROKE
HEBERT, PR
GAZIANO, JM
HENNEKENS, CH
[J]. ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (01) : 50 - 55
[10] Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor
Huhle, G
Abletshauser, C
Mayer, N
Weidinger, G
Harenberg, J
Heene, DL
[J]. THROMBOSIS RESEARCH, 1999, 95 (05) : 229 - 234

← 1 2 3 4 →